MX389771B - Compuestos de minociclina para biodefensas. - Google Patents

Compuestos de minociclina para biodefensas.

Info

Publication number
MX389771B
MX389771B MX2017012073A MX2017012073A MX389771B MX 389771 B MX389771 B MX 389771B MX 2017012073 A MX2017012073 A MX 2017012073A MX 2017012073 A MX2017012073 A MX 2017012073A MX 389771 B MX389771 B MX 389771B
Authority
MX
Mexico
Prior art keywords
biodefenses
bacterial infection
minocycline compounds
bacterium
treating
Prior art date
Application number
MX2017012073A
Other languages
English (en)
Other versions
MX2017012073A (es
Inventor
Michael P Draper
S Ken Tanaka
Original Assignee
Paratek Pharm Innc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paratek Pharm Innc filed Critical Paratek Pharm Innc
Publication of MX2017012073A publication Critical patent/MX2017012073A/es
Publication of MX389771B publication Critical patent/MX389771B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

En el presente documento se dan a conocer procedimientos para tratar o prevenir una infección bacteriana en un individuo, en donde la infección bacteriana es causada por una bacteria que puede usarse como arma biológica. También se describe una composición farmacéutica que comprende el compuesto de la presente invención para tratar o prevenir una infección bacteriana en un individuo, en donde la infección bacteriana es causada por una bacteria que puede usarse como arma biológica.
MX2017012073A 2015-03-24 2016-03-23 Compuestos de minociclina para biodefensas. MX389771B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562137719P 2015-03-24 2015-03-24
PCT/US2016/023807 WO2016154332A1 (en) 2015-03-24 2016-03-23 Minocycline compounds for biodefense

Publications (2)

Publication Number Publication Date
MX2017012073A MX2017012073A (es) 2018-02-21
MX389771B true MX389771B (es) 2025-03-20

Family

ID=56977663

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017012073A MX389771B (es) 2015-03-24 2016-03-23 Compuestos de minociclina para biodefensas.

Country Status (14)

Country Link
US (5) US20180133231A1 (es)
EP (2) EP4268897A3 (es)
JP (4) JP6826582B2 (es)
KR (3) KR20240051297A (es)
CN (2) CN116392496A (es)
AU (4) AU2016235151A1 (es)
CA (1) CA2980727C (es)
ES (1) ES2959665T3 (es)
FI (1) FI3273968T3 (es)
HU (1) HUE063795T2 (es)
IL (1) IL254622B2 (es)
MX (1) MX389771B (es)
PL (1) PL3273968T3 (es)
WO (1) WO2016154332A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240051297A (ko) * 2015-03-24 2024-04-19 파라테크 파마슈티컬스, 인크. 생물방어를 위한 미노시클린 화합물
KR102307799B1 (ko) * 2016-03-31 2021-10-01 닛산 가가쿠 가부시키가이샤 배향층형성 조성물
TWI746610B (zh) * 2016-08-03 2021-11-21 美商派瑞泰Ｓｐｖ２有限公司 9-胺甲基米諾四環素化合物及其用途
US10383884B2 (en) * 2016-11-01 2019-08-20 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)
CN112584827A (zh) * 2018-04-30 2021-03-30 梅琳塔治疗公司 用米诺环素治疗细菌感染的方法
LT3917616T (lt) 2019-01-31 2025-08-11 Takeda Pharmaceutical Company Limited Heterocikliniai junginiai ir jų naudojimas
CN111484424B (zh) * 2020-04-14 2022-10-25 成都百特万合医药科技有限公司 一种合成奥马环素的方法
PT117254B (pt) 2021-05-26 2024-04-18 Hovione Farm S A Método de síntese de compostos 9-aminometil tetraciclinas
CN114591216A (zh) * 2022-02-17 2022-06-07 四川澄华生物科技有限公司 一种合成奥马环素中间体的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100674047B1 (ko) 2000-07-07 2007-01-25 트러스티즈 오브 터프츠 칼리지 9-치환된 미노사이클린 화합물
WO2011101710A1 (en) * 2010-02-16 2011-08-25 Wockhardt Research Centre Efflux pump inhibitors
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
AU2003226112B9 (en) * 2002-03-29 2008-06-05 The Research Foundation Of State University Of New York Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
US7943600B2 (en) 2004-12-20 2011-05-17 Massachusetts Institute Of Technology Antimicrobial combination therapy
US20070238652A1 (en) * 2006-02-08 2007-10-11 Biosynexus Incorporated Neutralization of bacterial spores
US8440646B1 (en) 2006-10-11 2013-05-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of Bacillus anthracis infections
EP2213655A1 (en) 2007-04-27 2010-08-04 Paratek Pharmaceuticals, Inc. Methods For Purifying Aminoalkyl Tetracycline Compounds
AU2009220171A1 (en) * 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof
CA2873412A1 (en) * 2012-05-14 2013-11-21 Paratek Pharmaceuticals, Inc. Methods of using (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide
KR20240051297A (ko) * 2015-03-24 2024-04-19 파라테크 파마슈티컬스, 인크. 생물방어를 위한 미노시클린 화합물

Also Published As

Publication number Publication date
KR20170138439A (ko) 2017-12-15
US20200330489A1 (en) 2020-10-22
CN116392496A (zh) 2023-07-07
AU2020260450A1 (en) 2020-12-03
ES2959665T3 (es) 2024-02-27
AU2022256106A1 (en) 2022-11-24
IL254622B1 (en) 2023-09-01
IL254622B2 (en) 2024-01-01
JP2025023946A (ja) 2025-02-19
US20250367219A1 (en) 2025-12-04
EP3273968A4 (en) 2018-11-14
KR20240051297A (ko) 2024-04-19
JP2023022179A (ja) 2023-02-14
US20230098554A1 (en) 2023-03-30
JP2018509475A (ja) 2018-04-05
HUE063795T2 (hu) 2024-01-28
EP4268897A2 (en) 2023-11-01
WO2016154332A1 (en) 2016-09-29
CN107613988A (zh) 2018-01-19
MX2017012073A (es) 2018-02-21
CA2980727C (en) 2023-09-19
KR102656263B1 (ko) 2024-04-09
PL3273968T3 (pl) 2024-01-03
US20240238315A1 (en) 2024-07-18
CA2980727A1 (en) 2016-09-29
US20180133231A1 (en) 2018-05-17
IL254622A0 (en) 2017-11-30
EP4268897A3 (en) 2024-01-03
JP2021059544A (ja) 2021-04-15
AU2024202788A1 (en) 2024-05-23
FI3273968T3 (fi) 2023-10-09
KR20250151591A (ko) 2025-10-21
EP3273968A1 (en) 2018-01-31
EP3273968B1 (en) 2023-07-19
AU2020260450B2 (en) 2022-07-21
JP6826582B2 (ja) 2021-02-03
AU2016235151A1 (en) 2017-10-12
US11129839B2 (en) 2021-09-28

Similar Documents

Publication Publication Date Title
MX389771B (es) Compuestos de minociclina para biodefensas.
EA201891200A1 (ru) Композиции, содержащие бактериальные штаммы
EA201691766A1 (ru) Органические соединения, являющиеся монобактамами, для лечения бактериальных инфекций
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891970A1 (ru) Композиции, содержащие бактериальные штаммы
CY1122305T1 (el) Ενωσεις υδροξαζολης υδροξαμικου οξεος ως αναστολεις lpxc
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890051A1 (ru) Композиции, содержащие бактериальные штаммы
EA201791420A1 (ru) Соединения триазолопиримидина и их применения
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890050A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891347A1 (ru) Аза-бензимидазольные ингибиторы pad4
ZA202002093B (en) Antibacterial compounds
NZ724798A (en) Polymyxin derivatives as antimicrobial compounds
PH12016501988A1 (en) Antibacterial compounds
EA201691412A1 (ru) Гидроксиформамидные производные и их применение
BR112017011980A2 (pt) composto, composição farmacêutica, e, método para tratar uma infecção bacteriana.
EA201790464A1 (ru) Гетеробициклические соединения и их применение для лечения туберкулеза
EA201791530A1 (ru) НОВЫЕ N-АЦИЛАРИЛСУЛЬФОНАМИДНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ АМИНОАЦИЛ-тРНК СИНТЕТАЗЫ
PH12018500358A1 (en) Compounds for use in an antibacterial applications
EA201790156A1 (ru) Азетидинилоксифенилпирролидиновые соединения
EA201690227A1 (ru) Азаиндольные соединения, их получение и способы их применения